Posted On: 11/01/2014 11:31:12 AM
Post# of 102388
$AMGN Recent News
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Amgen, under investor pressure, outlines strategy 10:05 a.m. Oct. 28, 2014 - MarketWatch.com
Amgen's stock rises after company outlines capital allocation plans 9:07 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen's stock climbs 3.2% in premarket trade after capital allocation plans 8:55 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 revenue $20.8 bln-$21.3 bln vs. FactSet consensus $20.33 bln 8:54 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 adj. EPS $9.05-$9.40 vs. FactSet consensus $9.08 8:53 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to payout 60% of adj. earnings to shareholders through 2018 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to raise dividend 30% starting in Q1 2015 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen resumes share buybacks, with plans for $2 bln in repurchases through 2015 8:51 a.m. Oct. 28, 2014 - Tomi Kilgore
‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks 8:35 a.m. Oct. 28, 2014 - Shawn Langlois
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Newscast: Stocks mixed -- barely 6:46 p.m. Oct. 27, 2014 - MarketWatch
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Amgen posts strong results on higher sales 4:57 p.m. Oct. 27, 2014 - MarketWatch.com
Updates, advisories and surprises 4:31 p.m. Oct. 27, 2014 - MarketWatch
Amgen net drops, but adjusted earnings beat views 4:14 p.m. Oct. 27, 2014 - Russ Britt
Amgen GAAP net of $1.61 is below $1.81 view 4:06 p.m. Oct. 27, 2014 - Russ Britt
Amgen adj. net of $2.30 beats views of $2.11 4:05 p.m. Oct. 27, 2014 - Russ Britt
Amgen shares rise 1.9% following Q3 earnings release 4:04 p.m. Oct. 27, 2014 - Sue Chang
Amgen Q3 revenue is $5.03B vs. last year's $4.75B 4:04 p.m. Oct. 27, 2014 - Russ Britt
The Untouchables: Where Even Activist Investors Fear to Tread 2:58 p.m. Oct. 31, 2014 - TheStreet.com
AbbVie Beats Q3 Earnings Estimates, Raises Guidance 1:25 p.m. Oct. 31, 2014 - Investors Business Daily
Aegerion Q3 Loss Wider than Expected, 2014 View Lowered - Analyst Blog 11:32 a.m. Oct. 31, 2014 - Zacks.com
Amgen (AMGN) Hits New Lifetime High 9:47 a.m. Oct. 31, 2014 - TheStreet.com
United Therapeutics Sells Off On Good News - Why I Bought That Dip 3:52 p.m. Oct. 30, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: AIG, GS, AMGN 3:14 p.m. Oct. 30, 2014 - TheStreet.com
Amgen Continues To Offer The Best Value In Biotech 9:23 a.m. Oct. 30, 2014 - Seeking Alpha
Amgen: Great News Sends Shares To Fresh All-Time Highs 8:50 a.m. Oct. 30, 2014 - Seeking Alpha
Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings 8:21 a.m. Oct. 30, 2014 - 247WallSt.com
Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary 8:00 a.m. Oct. 30, 2014 - Zacks.com
10-Q: AMGEN INC 4:49 p.m. Oct. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog 3:05 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog 2:00 p.m. Oct. 29, 2014 - Zacks.com
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 12:28 p.m. Oct. 29, 2014 - Zacks.com
3 Health Care Picks To Beat Earnings - Earnings ESP 12:09 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success 11:34 a.m. Oct. 29, 2014 - Seeking Alpha
UPDATE: Nomura Upgrades Amgen 10:42 a.m. Oct. 29, 2014 - benzinga.com
Stock Market News for October 29, 2014 - Market News 10:10 a.m. Oct. 29, 2014 - Zacks.com
Analysts' Actions: Alibaba, Amazon.com, eBay, Cliffs Natural, More 8:50 a.m. Oct. 29, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: Alibaba, Amgen, Cliffs, Michael Kors, Sanofi, Yahoo! and More 8:28 a.m. Oct. 29, 2014 - 247WallSt.com
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
Xencor Renegotiates XmAb®5871 Agreement with Amgen; Regains All Rights and Plans Clinical Development in Rare Autoimmune Disease 4:00 p.m. Oct. 28, 2014 - PR Newswire - PRF
Amgen Outlines Strategy, Growth Objectives And Capital Allocation Plans 8:48 a.m. Oct. 28, 2014 - PR Newswire - PRF
Global and China Monoclonal Antibody Industry Report, 2014-2019 9:26 p.m. Oct. 27, 2014 - PR Newswire - PRF
Amgen's Third Quarter 2014 Revenues Increased 6 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $2.30 4:01 p.m. Oct. 27, 2014 - PR Newswire - PRF
Amgen To Webcast 2014 Business Review Meeting On October 28 5:39 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global Pediatric Drugs and Vaccines Market 5:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Amgen Announces Webcast of 2014 Third Quarter Financial Results 4:05 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) 5:59 p.m. Oct. 22, 2014 - PR Newswire - PRF
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) 5:54 p.m. Oct. 22, 2014 - PR Newswire - PRF
Amgen Statement Regarding Third Point Investment 3:41 p.m. Oct. 21, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma 9:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 4:17 p.m. Oct. 17, 2014 - PR Newswire - PRF
Amgen Announces 2014 Fourth Quarter Dividend 4:03 p.m. Oct. 17, 2014 - PR Newswire - PRF
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement 9:00 a.m. Oct. 17, 2014 - PR Newswire - PRF
Alirocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 6:40 p.m. Oct. 14, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
Amgen's BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Designation In Acute Lymphoblastic Leukemia 4:05 p.m. Oct. 9, 2014 - PR Newswire - PRF
Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Plaque Psoriasis 9:15 a.m. Oct. 8, 2014 - PR Newswire - PRF
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Amgen, under investor pressure, outlines strategy 10:05 a.m. Oct. 28, 2014 - MarketWatch.com
Amgen's stock rises after company outlines capital allocation plans 9:07 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen's stock climbs 3.2% in premarket trade after capital allocation plans 8:55 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 revenue $20.8 bln-$21.3 bln vs. FactSet consensus $20.33 bln 8:54 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 adj. EPS $9.05-$9.40 vs. FactSet consensus $9.08 8:53 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to payout 60% of adj. earnings to shareholders through 2018 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to raise dividend 30% starting in Q1 2015 8:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen resumes share buybacks, with plans for $2 bln in repurchases through 2015 8:51 a.m. Oct. 28, 2014 - Tomi Kilgore
‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks 8:35 a.m. Oct. 28, 2014 - Shawn Langlois
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Newscast: Stocks mixed -- barely 6:46 p.m. Oct. 27, 2014 - MarketWatch
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Amgen posts strong results on higher sales 4:57 p.m. Oct. 27, 2014 - MarketWatch.com
Updates, advisories and surprises 4:31 p.m. Oct. 27, 2014 - MarketWatch
Amgen net drops, but adjusted earnings beat views 4:14 p.m. Oct. 27, 2014 - Russ Britt
Amgen GAAP net of $1.61 is below $1.81 view 4:06 p.m. Oct. 27, 2014 - Russ Britt
Amgen adj. net of $2.30 beats views of $2.11 4:05 p.m. Oct. 27, 2014 - Russ Britt
Amgen shares rise 1.9% following Q3 earnings release 4:04 p.m. Oct. 27, 2014 - Sue Chang
Amgen Q3 revenue is $5.03B vs. last year's $4.75B 4:04 p.m. Oct. 27, 2014 - Russ Britt
The Untouchables: Where Even Activist Investors Fear to Tread 2:58 p.m. Oct. 31, 2014 - TheStreet.com
AbbVie Beats Q3 Earnings Estimates, Raises Guidance 1:25 p.m. Oct. 31, 2014 - Investors Business Daily
Aegerion Q3 Loss Wider than Expected, 2014 View Lowered - Analyst Blog 11:32 a.m. Oct. 31, 2014 - Zacks.com
Amgen (AMGN) Hits New Lifetime High 9:47 a.m. Oct. 31, 2014 - TheStreet.com
United Therapeutics Sells Off On Good News - Why I Bought That Dip 3:52 p.m. Oct. 30, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: AIG, GS, AMGN 3:14 p.m. Oct. 30, 2014 - TheStreet.com
Amgen Continues To Offer The Best Value In Biotech 9:23 a.m. Oct. 30, 2014 - Seeking Alpha
Amgen: Great News Sends Shares To Fresh All-Time Highs 8:50 a.m. Oct. 30, 2014 - Seeking Alpha
Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings 8:21 a.m. Oct. 30, 2014 - 247WallSt.com
Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary 8:00 a.m. Oct. 30, 2014 - Zacks.com
10-Q: AMGEN INC 4:49 p.m. Oct. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog 3:05 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog 2:00 p.m. Oct. 29, 2014 - Zacks.com
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 12:28 p.m. Oct. 29, 2014 - Zacks.com
3 Health Care Picks To Beat Earnings - Earnings ESP 12:09 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success 11:34 a.m. Oct. 29, 2014 - Seeking Alpha
UPDATE: Nomura Upgrades Amgen 10:42 a.m. Oct. 29, 2014 - benzinga.com
Stock Market News for October 29, 2014 - Market News 10:10 a.m. Oct. 29, 2014 - Zacks.com
Analysts' Actions: Alibaba, Amazon.com, eBay, Cliffs Natural, More 8:50 a.m. Oct. 29, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: Alibaba, Amgen, Cliffs, Michael Kors, Sanofi, Yahoo! and More 8:28 a.m. Oct. 29, 2014 - 247WallSt.com
Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire 9:15 a.m. Oct. 30, 2014 - PR Newswire - PRF
Xencor Renegotiates XmAb®5871 Agreement with Amgen; Regains All Rights and Plans Clinical Development in Rare Autoimmune Disease 4:00 p.m. Oct. 28, 2014 - PR Newswire - PRF
Amgen Outlines Strategy, Growth Objectives And Capital Allocation Plans 8:48 a.m. Oct. 28, 2014 - PR Newswire - PRF
Global and China Monoclonal Antibody Industry Report, 2014-2019 9:26 p.m. Oct. 27, 2014 - PR Newswire - PRF
Amgen's Third Quarter 2014 Revenues Increased 6 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 19 Percent To $2.30 4:01 p.m. Oct. 27, 2014 - PR Newswire - PRF
Amgen To Webcast 2014 Business Review Meeting On October 28 5:39 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global Pediatric Drugs and Vaccines Market 5:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Amgen Announces Webcast of 2014 Third Quarter Financial Results 4:05 p.m. Oct. 23, 2014 - PR Newswire - PRF
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) 5:59 p.m. Oct. 22, 2014 - PR Newswire - PRF
Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) 5:54 p.m. Oct. 22, 2014 - PR Newswire - PRF
Amgen Statement Regarding Third Point Investment 3:41 p.m. Oct. 21, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Amgen, Exelixis, Regeneron Pharma, Lexicon Pharma, and BioMarin Pharma 9:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 4:17 p.m. Oct. 17, 2014 - PR Newswire - PRF
Amgen Announces 2014 Fourth Quarter Dividend 4:03 p.m. Oct. 17, 2014 - PR Newswire - PRF
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement 9:00 a.m. Oct. 17, 2014 - PR Newswire - PRF
Alirocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 6:40 p.m. Oct. 14, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
Amgen's BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Designation In Acute Lymphoblastic Leukemia 4:05 p.m. Oct. 9, 2014 - PR Newswire - PRF
Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Plaque Psoriasis 9:15 a.m. Oct. 8, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼
